XIE; Dejian

Patent Applications and Registrations

Patent applications and USPTO patent grants for XIE; Dejian.The latest application filed is for "azazinoindazole derivative, preparation method therefor and use thereof".

Company Profile

2.8.14

XIE; Dejian - Chengdu Sichuan
Xie; Dejian - Pudong CN
Xie; Dejian - Shanghai CN
Xie; Dejian - Glenmount NY
Xie, Dejian - Glenmont NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Azazinoindazole Derivative, Preparation Method Therefor And Use Thereof App 20220194962 - XIE; Dejian ; et al.	2022-06-23
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20200030325 - van Duzer; John H. ; et al.	2020-01-30
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20160375021 - van Duzer; John H. ; et al.	2016-12-29
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20150045380 - van Duzer; John H. ; et al.	2015-02-12
Novel Substituted Indolo 4,3 Fg Quinolines Useful For Treating Migraine App 20140194434 - Cook; Robert O. ; et al.	2014-07-10
Novel Substituted Indolo 4,3 Fg Quinolines Useful For Treating Migraine App 20140194435 - COOK; Robert O. ; et al.	2014-07-10
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20140142117 - van Duzer; John H. ; et al.	2014-05-22
Substituted indolo 4,3 FG quinolines useful for treating migraine Grant 8,710,092 - Zhang , et al. April 29, 2	2014-04-29
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof Grant 8,609,678 - Van Duzer , et al. December 17, 2	2013-12-17
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof Grant 8,394,810 - van Duzer , et al. March 12, 2	2013-03-12
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20120190693 - van Duzer; John H. ; et al.	2012-07-26
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20120083504 - van Duzer; John H. ; et al.	2012-04-05
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof Grant 8,148,526 - van Duzer , et al. April 3, 2	2012-04-03
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof App 20110300134 - van Duzer; John H. ; et al.	2011-12-08
Novel Ergoline Analogs App 20110152280 - COOK; ROBERT O. ; et al.	2011-06-23
Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy App 20110124633 - Berman; Judd ; et al.	2011-05-26
Heterocyclic compounds, methods of making them and their use in therapy Grant 7,790,709 - Berman , et al. September 7, 2	2010-09-07
Heterocyclic compounds, methods of making them and their use in therapy App 20060183908 - Berman; Judd ; et al.	2006-08-17
Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia App 20050282819 - Graham, James M. ; et al.	2005-12-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.